ZBH — Zimmer Biomet Holdings Inc. stock price and chart

ZBH

Zimmer Biomet Holdings Inc.Stock · HealthcareS&P 500 Equal Weight 0.2% · S&P 500 0.03% · Russell 1000 0.02% · Russell 3000 0.02% · US Stock Market 0.02% · MSCI World 0.02% · MSCI ACWI 0.02%

$95.36+1.18%

as of market close, Sep 18, 2026

☀ Pre $96.20 +0.88%

PeersMRNALLYUNHJNJMRKTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD

20162019202120242026

90.0100.0110.0120.0130.0140.0150.0160.0170.0010.0M20.0M$95.36

2026-09-18

Price$95.36

MA20$91.83

MA50$94.04

Vol11.7M

What would $1,000 invested in ZBH be worth today? →

ZBH returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $95.36
Change YTD: +6.05%
Next earnings: Nov 4, 2026
Market cap: 18.2B2016-09 25.3B2026-09 18.2B-28.1% over the window
Enterprise value: 25.5B
Shares outstanding: 190.7M2016-06 200M2026-06 190.7M-4.6% over the window
52W low: $79.12
52W high: $106.88
From 52W high: -10.78%
From 52W low: +20.53%
52W range: 59%
Beta: 0.47

Volume

Rel volume: 2.04×
30D volume: 1.9M
30D $ vol: 189.3M

Fundamentals

Sales (ttm): 8.5B2016-12 7.7B2026-06 8.5B+11.0% over the window
Sales/share: $44.612016-12 $38.132026-06 $44.61+17.0% over the window
EPS (ttm): $4.112016-06 $1.112026-06 $4.11+270.2% over the window
FCF (ttm): 1.5B2016-06 1B2026-06 1.5B+46.9% over the window
FCF/share: $7.982016-06 $5.182026-06 $7.98+54.0% over the window
Book value/share: $66.182016-06 $47.742026-06 $66.18+38.6% over the window
Net margin: 9.48%2016-12 4.0%2026-06 9.5%+137.6% over the window
ROE: 6.39%2016-06 2.4%2026-06 6.4%+169.1% over the window
ROA: 3.54%2016-06 0.9%2026-06 3.5%+305.3% over the window
Debt / equity: 0.50×2016-06 1.102026-06 0.50-54.9% over the window
Current ratio: 1.692016-06 2.402026-06 1.69-29.6% over the window

Growth (CAGR, ttm) · 10Y

Sales: +8.62%2025-06-30 → 2026-06-307.8B → 8.5B (+8.6% total)+5.75%2023-06-30 → 2026-06-307.2B → 8.5B (+18.3% total)+2.89%2021-06-30 → 2026-06-307.4B → 8.5B (+15.3% total)+1.10%2016-12-31 → 2026-06-307.7B → 8.5B (+11.0% total)
Net income: -2.04%2025-06-30 → 2026-06-30823.4M → 806.6M (-2.0% total)+16.84%2023-06-30 → 2026-06-30505.6M → 806.6M (+59.5% total)-2.52%2021-06-30 → 2026-06-30916.2M → 806.6M (-12.0% total)+13.53%2016-06-30 → 2026-06-30226.7M → 806.6M (+255.8% total)
FCF: +3.45%2025-06-30 → 2026-06-301.5B → 1.5B (+3.4% total)+11.59%2023-06-30 → 2026-06-301.1B → 1.5B (+39.0% total)+1.65%2021-06-30 → 2026-06-301.4B → 1.5B (+8.5% total)+3.92%2016-06-30 → 2026-06-301B → 1.5B (+46.9% total)
Shares: -3.72%2025-06-30 → 2026-06-30198.1M → 190.7M (-3.7% total)-3.00%2023-06-30 → 2026-06-30209M → 190.7M (-8.7% total)-1.80%2021-06-30 → 2026-06-30208.8M → 190.7M (-8.7% total)-0.47%2016-06-30 → 2026-06-30200M → 190.7M (-4.6% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: -0.07%2025-06-30 → 2026-06-30$4.11 → $4.11 (-0.1% total)+19.56%2023-06-30 → 2026-06-30$2.40 → $4.11 (+70.9% total)-1.18%2021-06-30 → 2026-06-30$4.36 → $4.11 (-5.8% total)+13.99%2016-06-30 → 2026-06-30$1.11 → $4.11 (+270.2% total)
Sales/share: +12.82%2025-06-30 → 2026-06-30$39.55 → $44.61 (+12.8% total)+9.01%2023-06-30 → 2026-06-30$34.43 → $44.61 (+29.6% total)+4.77%2021-06-30 → 2026-06-30$35.33 → $44.61 (+26.3% total)+1.67%2016-12-31 → 2026-06-30$38.13 → $44.61 (+17.0% total)
FCF/share: +7.44%2025-06-30 → 2026-06-30$7.43 → $7.98 (+7.4% total)+15.03%2023-06-30 → 2026-06-30$5.24 → $7.98 (+52.2% total)+3.51%2021-06-30 → 2026-06-30$6.72 → $7.98 (+18.8% total)+4.41%2016-06-30 → 2026-06-30$5.18 → $7.98 (+54.0% total)
Book value/share: +4.68%2025-06-30 → 2026-06-30$63.23 → $66.18 (+4.7% total)+3.78%2023-06-30 → 2026-06-30$59.20 → $66.18 (+11.8% total)+1.90%2021-06-30 → 2026-06-30$60.23 → $66.18 (+9.9% total)+3.32%2016-06-30 → 2026-06-30$47.74 → $66.18 (+38.6% total)
Dividend/share: +0.00%2025-06-30 → 2026-06-30$0.96 → $0.96 (+0.0% total)+0.00%2023-06-30 → 2026-06-30$0.96 → $0.96 (+0.0% total)+0.00%2021-06-30 → 2026-06-30$0.96 → $0.96 (+0.0% total)+0.43%2016-06-30 → 2026-06-30$0.92 → $0.96 (+4.3% total)
Price: -4.84%2025-09-18 → 2026-09-18$100.21 → $95.36 (-4.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-7.89%2023-09-18 → 2026-09-18$122.03 → $95.36 (-21.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-7.71%2021-09-17 → 2026-09-18$142.45 → $95.36 (-33.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-2.33%2016-09-16 → 2026-09-18$120.68 → $95.36 (-21.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: -3.84%2025-09-18 → 2026-09-18$99.17 → $95.36 (-3.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-7.03%2023-09-18 → 2026-09-18$118.67 → $95.36 (-19.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-6.91%2021-09-17 → 2026-09-18$136.41 → $95.36 (-30.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-1.52%2016-09-16 → 2026-09-18$111.14 → $95.36 (-14.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 23.2×2016-09 69.602026-09 22.55-67.6% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 15.1×2016-09 29.532026-09 15.09-48.9% over the window
Fwd P/E: 10.5×
P/S (ttm)Market cap ÷ TTM revenue.: 2.1×2016-09 5.922026-09 2.14-63.9% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 1.4×2016-09 2.592026-09 1.44-44.5% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 11.9×2016-09 19.632026-09 11.94-39.1% over the window
EV/EBITDA (fy): 11.0×
EV/Sales (ttm): 3.0×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 8.37%2016-06 4.1%2026-06 9.5%+130.9% over the window
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 1.01%
Dividend/share (fwd): $0.96
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 190.7M ÷ 198.1M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 3.72%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (3.72%) + dividends paid over that year ($188.4M) ÷ market_cap_at(2025-06-30) ($18.1B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 4.76%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($750.8M) ÷ today's market cap ($18.2B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 4.13%2016-06 2.2%2026-06 4.7%+108.8% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $750.8M + TTM dividends $188.4M) ÷ today's market cap ($18.2B). Same caveat as the cash buyback yield.: 5.16%2016-06 2.9%2026-06 5.8%+99.5% over the window

Vs own 10Y history

P/E: 25th
P/OI: 8th
P/S: 4th
P/B: 6th
P/FCF: 4th

Bar = where today’s multiple sits in ZBH’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-09-18

+1.18%

+2.00%

-3.82%

+8.40%

YTD

+6.05%

-4.84%

-33.06%

Financial statements

Open full ZBH financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-5.94%	+0.04%
JNJ	Johnson & Johnson	-0.41%	-0.09%
ABBV	AbbVie Inc.	+1.95%	-0.02%
MRK	Merck & Co. Inc.	+8.66%	-0.19%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-4.32%	+0.45%
TMO	Thermo Fisher Scientific Inc.	+10.60%	-1.04%
AMGN	Amgen Inc.	-9.32%	+1.55%
GILD	Gilead Sciences Inc.	+4.65%	-0.52%

Zimmer Biomet Holdings Inc. (ZBH) trades at $95.36 with a live price and an interactive chart covering 25+ years of daily price history, plus key valuation metrics. ChartRow also publishes ZBH’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full ZBH financial statements →

ZBH — Zimmer Biomet Holdings Inc. price, chart and key statistics